High-dose sequential chemotherapy and rituximab (R-HDS) supported by autologous stem cell transplantation (ASCT) in patients (pts) with systemic B-cell lymphoma with CNS involvement (SCNSL) at diagnosis or relapse: Interim analysis of feasibility and activity of a phase II trial.

医学 美罗华 内科学 阿糖胞苷 自体干细胞移植 胃肠病学 中性粒细胞减少症 依托泊苷 环磷酰胺 噻替帕 化疗 肿瘤科 移植 外科 淋巴瘤
作者
Andrea Assanelli,K. Patti,S Cortelazzo,Luigi Rigacci,Liliana Devizzi,Marco Foppoli,Antonino Mulè,Fabio Ciceri,Corrado Tarella,Andrés J.M. Ferreri
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
卷期号:28 (15_suppl): 8081-8081 被引量:1
标识
DOI:10.1200/jco.2010.28.15_suppl.8081
摘要

8081 Background: High-dose (HD) chemotherapy supported by ASCT exhibited promising results in a few, small retrospective series of SCNSL. Herein we report the interim analysis of a phase II trial (ClinicalTrials.gov #NCT00801216) addressing a new R-HDS combination with ASCT in these poor-prognosis pts. Methods: Pts (≤65 ys old; ECOG PS 0-3) with SCNSL at diagnosis or relapse were treated with 2 c. of HD-methotrexate + HD-cytarabine (induction); 3 sequential c. of HD-cyclophosphamide, HD-cytarabine, HD-etoposide (R-HDS); BCNU-thiotepa-based conditioning and ASCT. Pts received 6 doses of i.v. rituximab and 4 doses of intrathecal liposomal cytarabine. Pts with CNS residual disease were referred to RT. The 2-year EFS is the primary endpoint (P0 40%; P1 60%; 38 pts required). This approach will be considered active if ≥21 pts will be progression free at 2 yrs. Results: the first 13 registered pts (median age 52 ys, 31-65; M/F ratio 1.6) were analyzed. Six pts were treated at diagnosis; 8 had systemic disease; no pt had positive CSF. Histotypes were diffuse large B-cell (10), mantle cell (2) and follicular (1) lymphomas. Bulky disease (1), ECOG-PS 2-3 (4) and B-symptoms (1) were uncommon; elevated LDH levels were observed in 10 pts. Treatment was completed in 8 pts, is ongoing in 3 (R-HDS), and was interrupted in 2: before conditioning in a poor mobilizer and after the first course due to PD. There were no toxic deaths. G4 neutropenia and thrombocytopenia were reported in all pts, febrile neutropenia in 7, other septic complications in 5. G3-4 non-hematological toxicity was not reported. PBSC collection was successful in 8 of the 9 referred pts (median 9.35 × 109/kg). Nine (69%) pts achieved a CR, 3 a PR (ORR 92%), 1 pt had PD. No pt received RT. At a median f-up of 15 m, 4 pts experienced relapse/PD (CNS 3, extra-CNS 1), with a 2-yr EFS of 46%; 9 pts are alive with a 2-yr OS of 54%. Conclusions: R-HDS supported by ASCT is feasible in pts ≤65 ys old with SCNSL. Preliminary results with this intensive approach are encouraging in this condition, with otherwise dismal prognosis. No significant financial relationships to disclose.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助21采纳,获得10
刚刚
善学以致用应助James采纳,获得10
1秒前
2秒前
星业辰完成签到,获得积分10
4秒前
暴躁小兔完成签到,获得积分10
4秒前
勤恳完成签到,获得积分10
5秒前
6秒前
7秒前
bkagyin应助幽默钢笔采纳,获得10
9秒前
9秒前
14秒前
terence完成签到,获得积分10
15秒前
在水一方应助带帽采纳,获得10
15秒前
15秒前
16秒前
lailai完成签到 ,获得积分10
17秒前
科研通AI5应助诚心的平松采纳,获得10
19秒前
James发布了新的文献求助10
21秒前
研友_LBKOgn完成签到,获得积分20
22秒前
Ava应助CartGo采纳,获得10
24秒前
俏皮的采波完成签到,获得积分10
24秒前
JamesPei应助吕妍采纳,获得30
27秒前
aaa完成签到 ,获得积分10
29秒前
21发布了新的文献求助10
29秒前
冷傲迎梦完成签到,获得积分20
30秒前
不倦应助1234采纳,获得10
32秒前
阿南完成签到 ,获得积分10
34秒前
zhong完成签到,获得积分10
35秒前
37秒前
kxy完成签到,获得积分10
39秒前
美好的思松完成签到,获得积分10
40秒前
41秒前
土豆完成签到,获得积分10
41秒前
科研通AI5应助真凉大魔王采纳,获得10
43秒前
生动听筠发布了新的文献求助30
43秒前
陈瑶完成签到,获得积分10
44秒前
xiaolu发布了新的文献求助10
46秒前
赶紧毕业发布了新的文献求助10
47秒前
48秒前
迷人世开完成签到,获得积分10
48秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Conference Record, IAS Annual Meeting 1977 820
England and the Discovery of America, 1481-1620 600
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3572635
求助须知:如何正确求助?哪些是违规求助? 3142841
关于积分的说明 9449037
捐赠科研通 2844177
什么是DOI,文献DOI怎么找? 1563386
邀请新用户注册赠送积分活动 731723
科研通“疑难数据库(出版商)”最低求助积分说明 718679